Mercury Pharmaceuticals

We are de-risking biomedical innovations, while turning biomedical knowledge into social and economic value.

Stay Informed!

Large-scale meteorological patterns linked to Ebola virus outbreaks

22

Oct 2026

Large-scale meteorological patterns linked to Ebola virus outbreaks

A study led by the University of Malaga has shown that outbreaks of Ebola virus do not occur randomly over time; rather, their appearance is linked to specific large-scale meteorological patterns, even with oscillations occurring in regions thousands of miles away from Central Africa, where they are currently suffering from an epidemic of this disease, which can be fatal.

ESMO updates precision oncology framework to improve targeted therapies

22

Oct 2026

ESMO updates precision oncology framework to improve targeted therapies

ESMO has published version 2 of the ESMO Scale for Clinical Actionability of molecular Targets (ESCAT), a major update to the internationally recognized precision oncology framework that helps oncologists assess the clinical relevance of molecular alterations and match patients with the most appropriate targeted therapies.

Obesity impairs key immune cells but bariatric surgery reverses damage

22

Oct 2026

Obesity impairs key immune cells but bariatric surgery reverses damage

New Maynooth University (MU) research led by the Department of Biology's Dr Ciara Flynn, working within the research group of Prof Andrew Hogan at the Kathleen Lonsdale Institute for Human Health Research has found that obesity can impair key immune cells that help protect the body against infection and cancer.

MERCURY trials

Clinical trials are very important as it allow us to evaluate the effectiveness of new drugs, new devices, preventative strategies or treatment strategies. It also enables us to discover better ways for patients' care.
- Learn more

Cancer

Our mission remains constant as we endeavor to deliver novel medicines to patients with cancer, treating solid tumors with high unmet medical needs in well-defined patient populations that are currently not well supported.
- Learn more

Neuroscience

Whether you're looking to manufacture toxicology batches or cGMP material for clinical trials, we can help you expedite molecules to clinic with full transparency.
- Learn more

Mercury Pharmaceuticals

Why Us?

Strong experience in academic research and technology transfer makes us understand your goals and motivations as a technology originator.
Our experience in drug development from discovery to clinical and commercial stages makes us an insider player within the biopharmaceutical industry.
Smart approach to project management that helps speed up development stages and decision making.
Availability of own investment up to 2m€ per project allows us to reach the next value milestone.